Sign up online today & collaborate
or click here to find out more
Bayer is developing plans to overhaul its corporate structure to more closely align its two life sciences businesses, but says the move will not see any staff reductions.
Announcing first quarter figures that saw sales rise 14.8% to €12.1bn, the company said its corporate structure is currently being examined and a range of restructuring proposals were being set out.
Management board chairman Dr Marijn Dekkers said: “I must emphasise in this connection that it is not about cutting jobs. We continue to anticipate that the number of employees at Bayer will remain stable in the coming years, both worldwide and in Germany.”
He added: “We are convinced that Bayer has outstanding growth perspectives as a pure life science company.”For more click here